- Report
- May 2024
- 130 Pages
Global
From €3542EUR$3,950USD£3,037GBP
- Report
- January 2023
- 132 Pages
Global
From €3991EUR$4,450USD£3,422GBP
- Report
- March 2026
- 150 Pages
Canada
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2026
- 180 Pages
China
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2026
- 214 Pages
Germany
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2026
- 248 Pages
India
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
Canada
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
China
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
Germany
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
India
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
Canada
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
China
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
India
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 173 Pages
Canada
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 182 Pages
China
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 174 Pages
Germany
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 175 Pages
India
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 178 Pages
Japan
From €4349EUR$4,850USD£3,729GBP
- Report
- January 2026
- 150 Pages
Japan
From €4349EUR$4,850USD£3,729GBP
- Report
- January 2026
- 150 Pages
India
From €4349EUR$4,850USD£3,729GBP

The Vaccines market is a sector of the pharmaceutical industry that focuses on the development, production, and distribution of vaccines. Vaccines are used to prevent and treat infectious diseases, and are an important part of public health initiatives. Vaccines are typically developed by pharmaceutical companies, and then approved by regulatory bodies such as the US Food and Drug Administration (FDA).
The Vaccines market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies are involved in the development, production, and distribution of a wide range of vaccines, including those for influenza, measles, mumps, rubella, and hepatitis. Smaller companies are also involved in the Vaccines market, such as Emergent BioSolutions and Bavarian Nordic. Show Less Read more